Industry-Leading Addiction Experts

Led by Dr. Konis, Board Certified in Addiction Medicine, ERG clinicians use of buprenorphine and have the necessary skills to provide patient counseling. We augment those skills with deep knowledge of the regulatory requirements around working with controlled substances in clinical and research settings, including experience in injection, oral, nasal, infusion, and adhesion delivery systems. Our experts are certified to administer and review a wide range of screening, diagnostic, and assessment scales used in addiction studies. These include: The Addiction Severity Index (ASI), Structured Clinical Interview for DSM-IV (SCID), Modified Mini International Neuropsychiatric Interview Screen (MINI), and DSM V for diagnosis; and the CAGE Questionnaire, Michigan Alcohol Screen Testing (MAST), and Alcohol Use Disorders Identification Test (AUDIT) for screening. Other assessment scales include the Other assessment scales include the Timeline Followback (TLFB), Cocaine Craving Questionnaire (CCQ), Penn Alcohol Craving Scale (PACS), Yale-Brown Obsessive Compulsive Scale (YBOC), Clinical Opiate Withdrawal Scale (COWS), Subjective Opiate Withdrawal Scale (SOWS), Quality of Life Scale (QoL), Symptom Checklist 90 Revised (SCL-90 R), Scales of Psychological Wellbeing (SPWB), Clinical Global Impression (CGI), and Global Assessment of Functioning Scale (GAF).

With the staggering incidence of patients with substance abuse disorders, ERG has established an unparalleled pipeline of clinical study subjects, continually augmented by physician and patient referrals and robust advertising initiatives. We achieve retention through patient-friendly programs, such as transportation for outpatient visits and smoking rooms for confinement periods.